These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


69 related items for PubMed ID: 15031672

  • 21. uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells.
    Lester RD, Jo M, Montel V, Takimoto S, Gonias SL.
    J Cell Biol; 2007 Jul 30; 178(3):425-36. PubMed ID: 17664334
    [Abstract] [Full Text] [Related]

  • 22. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor.
    Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K, Graff BA.
    Cancer Res; 2002 Mar 15; 62(6):1847-53. PubMed ID: 11912164
    [Abstract] [Full Text] [Related]

  • 23. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells.
    Kim MH, Cho HS, Jung M, Hong MH, Lee SK, Shin BA, Ahn BW, Jung YD.
    Int J Oncol; 2005 Jun 15; 26(6):1669-74. PubMed ID: 15870884
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.
    Yan Q, Bach DQ, Gatla N, Sun P, Liu JW, Lu JY, Paller AS, Wang XQ.
    Mol Cancer Res; 2013 Jun 15; 11(6):665-75. PubMed ID: 23525268
    [Abstract] [Full Text] [Related]

  • 26. A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts.
    Mazzieri R, Furlan F, D'Alessio S, Zonari E, Talotta F, Verde P, Blasi F.
    Oncogene; 2007 Feb 01; 26(5):725-32. PubMed ID: 16878153
    [Abstract] [Full Text] [Related]

  • 27. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.
    Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K.
    Cancer Res; 2005 Mar 15; 65(6):2387-96. PubMed ID: 15781654
    [Abstract] [Full Text] [Related]

  • 28. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
    Taniguchi T, Kakkar AK, Tuddenham EG, Williamson RC, Lemoine NR.
    Cancer Res; 1998 Oct 01; 58(19):4461-7. PubMed ID: 9766679
    [Abstract] [Full Text] [Related]

  • 29. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
    Sprague LD, Tomaso H, Mengele K, Schilling D, Bayer C, Stadler P, Schmitt M, Molls M.
    Oncol Rep; 2007 May 01; 17(5):1259-68. PubMed ID: 17390074
    [Abstract] [Full Text] [Related]

  • 30. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
    Baek MK, Kim MH, Jang HJ, Park JS, Chung IJ, Shin BA, Ahn BW, Jung YD.
    Oncol Rep; 2008 Dec 01; 20(6):1569-75. PubMed ID: 19020743
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Guevorkian M, Edmiston M, Zhao D, Glackin CA, Kim SU, Aboody KS.
    Stem Cells; 2008 Jun 01; 26(6):1406-13. PubMed ID: 18403751
    [Abstract] [Full Text] [Related]

  • 33. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
    Chang HJ, Kim MH, Baek MK, Park JS, Chung IJ, Shin BA, Ahn BW, Jung YD.
    Anticancer Res; 2007 Jun 01; 27(5A):3411-7. PubMed ID: 17970088
    [Abstract] [Full Text] [Related]

  • 34. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
    Kukreja P, Abdel-Mageed AB, Mondal D, Liu K, Agrawal KC.
    Cancer Res; 2005 Nov 01; 65(21):9891-8. PubMed ID: 16267013
    [Abstract] [Full Text] [Related]

  • 35. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 36. Fatty acids differentially modify the expression of urokinase type plasminogen activator receptor in monocytes.
    Assmann A, Möhlig M, Osterhoff M, Pfeiffer AF, Spranger J.
    Biochem Biophys Res Commun; 2008 Nov 07; 376(1):196-9. PubMed ID: 18762175
    [Abstract] [Full Text] [Related]

  • 37. Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases.
    Margheri F, D'Alessio S, Serratí S, Pucci M, Annunziato F, Cosmi L, Liotta F, Angeli R, Angelucci A, Gravina GL, Rucci N, Bologna M, Teti A, Monia B, Fibbi G, Del Rosso M.
    Gene Ther; 2005 Apr 07; 12(8):702-14. PubMed ID: 15674398
    [Abstract] [Full Text] [Related]

  • 38. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 39. Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor.
    Rofstad EK, Mathiesen B, Galappathi K.
    Cancer Res; 2004 Jan 01; 64(1):13-8. PubMed ID: 14729600
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.